Regression of Intracranial Meningioma during Treatment with α1-Adrenoceptor Blocker.

J Neurol Surg Rep

Department of Neurosurgery, Oslo University Hospital Rikshospitalet, Oslo, Norway; Faculty of Medicine, University of Oslo, Oslo, Norway.

Published: March 2016

Background Regression of meningioma has been reported after hemorrhage or hormonal withdrawal. Here, we report a case of an incidentally diagnosed meningioma that regressed in association with α1-adrenoceptor antagonist. Case report A 59-year old male patient with an incidentally diagnosed lateral sphenoid wing meningioma was followed with serial magnetic resonance imaging. The tumor with a maximum diameter of 43 mm showed progressive regression, and after 3 years the size was reduced to 22% of the initial volume. During follow-up the patient was treated with an α1-adrenoceptor antagonist (tamsulosin) for benign prostatic hyperplasia. Possible mechanisms are discussed, including our main hypothesis of reduced mitogenic effects through phospholipase C-signal transduction. Conclusion This is the first report of regression of an incidentally diagnosed meningioma associated with α1-adrenoceptor antagonist treatment.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4863873PMC
http://dx.doi.org/10.1055/s-0035-1571204DOI Listing

Publication Analysis

Top Keywords

incidentally diagnosed
12
α1-adrenoceptor antagonist
12
diagnosed meningioma
8
meningioma
5
regression intracranial
4
intracranial meningioma
4
meningioma treatment
4
α1-adrenoceptor
4
treatment α1-adrenoceptor
4
α1-adrenoceptor blocker
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!